Zyla Life Sciences Increase (Decrease) in Accounts Receivable
Zyla Life Sciences reported Increase (Decrease) in Accounts Receivable of $5.37 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2020-05-14
- Zyla Life Sciences increase (decrease) in accounts receivable for the quarter ending 2020-03-31 was $5.37M.
- Zyla Life Sciences increase (decrease) in accounts receivable for the quarter ending 2018-12-31 was -$2.83M.
- Zyla Life Sciences increase (decrease) in accounts receivable for the quarter ending 2018-09-30 was $1.76M, a 251.60% increase year-over-year.
- Zyla Life Sciences increase (decrease) in accounts receivable for the quarter ending 2018-06-30 was -$5.90M.
- Zyla Life Sciences increase (decrease) in accounts receivable for fiscal 2018 was $4.26M, a 41.33% increase from fiscal 2017.
- Zyla Life Sciences increase (decrease) in accounts receivable for fiscal 2017 was $3.01M, a 270.48% increase from fiscal 2016.
- Zyla Life Sciences increase (decrease) in accounts receivable for fiscal 2016 was $813.00K, a 175.59% increase from fiscal 2015.
- Zyla Life Sciences increase (decrease) in accounts receivable for fiscal 2015 was $295.00K.
| Period end | Increase (Decrease) in Accounts Receivable 1 month | Increase (Decrease) in Accounts Receivable 2 month | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 5 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 8 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 11 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $5.37M 10-Q · filed 2020-05-14 | ||||||||
| 2019-12-31 | $21.56M 10-K · filed 2020-03-26 | ||||||||
| 2019-09-30 | $22.44M 10-Q · filed 2019-11-14 | ||||||||
| 2019-06-30 | $17.07M 10-Q · filed 2019-08-13 | ||||||||
| 2019-03-31 | $35.80M 10-Q · filed 2020-05-14 | ||||||||
| 2019-01-31 | -$3.87M 10-Q · filed 2020-05-14 | ||||||||
| 2018-12-31 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$1.08M derived: sum of 2 quarters · filed 2020-03-26 | -$6.98M derived: sum of 3 quarters · filed 2020-03-26 | $4.26M 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$4.14M derived: sum of 2 quarters · filed 2019-11-14 | $7.09M 10-Q · filed 2019-11-14 | $5.61M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | -$5.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $5.33M 10-Q · filed 2018-08-09 | $3.85M derived: sum of 3 quarters · filed 2019-03-29 | $4.35M derived: sum of 4 quarters · filed 2019-03-29 | |||||
| 2018-03-31 | $11.23M 10-Q · filed 2018-05-10 | $9.75M derived: sum of 2 quarters · filed 2019-03-29 | $10.25M derived: sum of 3 quarters · filed 2019-03-29 | $9.94M derived: sum of 4 quarters · filed 2019-03-29 | |||||
| 2017-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$987.00K derived: sum of 2 quarters · filed 2019-03-29 | -$1.29M derived: sum of 3 quarters · filed 2019-03-29 | $3.01M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | $197.00K derived: sum of 2 quarters · filed 2018-11-19 | $4.50M 10-Q · filed 2018-11-19 | $1.72M derived: sum of 4 quarters · filed 2018-11-19 | |||||
| 2017-06-30 | -$303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.00M 10-Q · filed 2018-08-09 | $1.22M derived: sum of 3 quarters · filed 2018-08-09 | $4.29M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | $4.30M 10-Q · filed 2018-05-10 | $1.52M derived: sum of 2 quarters · filed 2018-05-10 | $4.59M derived: sum of 3 quarters · filed 2018-05-10 | $4.58M derived: sum of 4 quarters · filed 2018-05-10 | |||||
| 2016-12-31 | -$2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $288.00K derived: sum of 2 quarters · filed 2018-03-16 | $279.00K derived: sum of 3 quarters · filed 2018-03-16 | $813.00K 10-K · filed 2018-03-16 | |||||
| 2016-09-30 | $3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $3.06M derived: sum of 2 quarters · filed 2017-11-08 | $3.60M 10-Q · filed 2017-11-08 | ||||||
| 2016-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $525.00K 10-Q · filed 2017-08-09 | |||||||
| 2016-03-31 | $534.00K 10-Q · filed 2017-05-10 | ||||||||
| 2015-12-31 | $295.00K 10-K · filed 2018-03-16 | ||||||||
| 2012-12-31 | -$96.00K 10-K · filed 2015-03-16 |